Clinical Trial Update: Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) [Phase 4]

View source ↗

Summary

The Phase 4 ART-CAP trial evaluating aggressive risk-prevention therapies for coronary atherosclerotic plaque has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Myocardial Infarction

Snippet

Sponsor: University of Louisville | Conditions: Coronary Artery Disease, Atherosclerosis | Phase 4 | Status: WITHDRAWN